StreetAlpha.app
Home › Stocks › CLOV

Clover Health Investments, Corp. (CLOV)

Healthcare
$3.73
▼ −1.06%
LAST CLOSE · NOV 20

Clover Health sells Medicare Advantage health plans and Clover Assistant, a software platform that helps physicians manage chronic diseases. It last closed at $3.73 on Nov 20, down 1.06% on the day. The next earnings report for CLOV is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, CLOV reported EPS of $0.01 on revenue of $759.3M, with revenue up 52.9% from a year ago. Over its last 8 reports the stock moved an average of 9.8% the session after earnings. Over the last 12 months CLOV insiders bought $0 of stock on the open market and sold $8.8M, according to SEC Form 4 filings.

AI Auto Pilots
Is CLOV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CLOV.

Key Stats

Last 12 months
Results
Revenue
$2.7B
+54.5% vs a year ago
Net income
$12.4M
0.5% margin
Free cash flow
$132.3M
4.8% margin
Operating margin
0.7%
$18.9M operating income
Balance sheet
Cash & equivalents
$268.1M
At Sep 30
Shareholder equity
$390.9M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.5B$1.5BFY2021FY2022: $1.1B$1.1BFY2022FY2023: $1.3B$1.3BFY2023FY2024: $1.4B$1.4BFY2024FY2025: $1.9B$1.9BFY2025

From CLOV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · After the close
Reported EPS
$0.01
Quarter ended Sep 2026
Year ago EPS
-$0.05
Same quarter last year
Revenue
$759.3M
+52.9% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Mar 2025: $0.00Mar '25Jun 2025: -$0.02Jun '25Sep 2025: -$0.05Sep '25Mar 2026: $0.05Mar '26Jun 2026: $0.05Jun '26Sep 2026: $0.01Sep '26Latest $0.01
Revenue by quarter
Dec 2024: $337.0MDec '24Mar 2025: $462.3MMar '25Jun 2025: $477.6MJun '25Sep 2025: $496.6MSep '25Dec 2025: $487.7MDec '25Mar 2026: $749.2MMar '26Jun 2026: $743.2MJun '26Sep 2026: $759.3MSep '26Latest $759.3M
How CLOV moved after its last 8 reports
Average move the session after a report ±9.8%
Nov 4, 2026After the close−4.5%
Aug 5, 2026After the close+12.6%
May 6, 2026After the close+5.2%
Feb 26, 2026After the close−2.8%
Aug 5, 2025After the close−20.7%
May 6, 2025After the close+12.5%
Feb 27, 2025After the close−4.1%
Nov 6, 2024After the close−15.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CLOVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CLOV
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CLOV

Technical Analysis

CLOV · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 23% below its 20 day and 23% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 31), near oversold. The nearest support is the 200 day average at $3.70, and the nearest resistance the Pivot at $3.79.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 8.5%/day
Key levels
$5.5952 week high+49.9%
$4.5950 day average+23.1%
$4.5820 day average+22.8%
$4.52100 day average+21.2%
$4.23Swing high (May 28)+13.4%
$3.90Pivot R1+4.6%
$3.79Pivot+1.6%
$3.73Last close
$3.70200 day average−0.8%
$3.62Pivot S1−2.9%
$3.58Swing low (Jun 3)−4.0%
$1.5852 week low−57.6%
Indicators
RSI (14)30.79Weak, oversold below 30Neutral
MACD-0.11Below its signal lineBearish
Stochastic2.9Near the bottom of its rangeOversold
ADX (14)22.2Weak trend
Williams %R-96.9Oversold below −80, overbought above −20Oversold
CCI (20)-222.5Oversold below −100, overbought above 100Oversold
Rate of change−22.6%Change over 10 sessionsBearish
ATR (14)$0.32Typical daily range, 8.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for CLOV

What happened before

See how CLOV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CLOV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CLOV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CLOVHow many large options trades hit CLOV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

CLOV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲119 buying vs 85 selling
  • ▲Shares held by funds +7.5%
  • ▲Funds holding +3
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding230227+1.3%
In funds' top 1000–
Held by funds–––
New / increased42 / 7743 / 77−0.8%
Reduced / sold out48 / 3754 / 25+7.6%
Put/call ratio0.260.18+44.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CLOV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CLOV Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$8.8M42 sales · 8 insiders
87% of the selling was under pre-arranged trading plans.
2025-12 sold $13K2026-01 sold $17K2026-03 sold $391K2026-05 sold $1.5M2026-06 sold $157K2026-07 sold $2.5M2026-08 sold $486K2026-09 sold $1.6M2026-10 sold $2.1M2026-11 sold $110KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Joseph Clay ThorntonCFOSale22,099$4.97$110K
Oct 20Karen SoaresChief Legal OfficerSale plan19,275$4.66$90K
Oct 19Jamie L. ReynosoCEO, Medicare AdvantageSale plan4,066$4.41$18K
Oct 15Jamie L. ReynosoCEO, Medicare AdvantageSale plan18,273$4.68$86K
Oct 15Conrad WaiCEO, Counterpart HealthSale plan23,627$4.68$111K
Oct 15Joseph Clay ThorntonInterim CFOSale plan4,591$4.68$21K
Every insider buy and sale for CLOV over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CLOV insider trades →

From SEC Form 4 filings by CLOV's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CLOV is in one of them and how their past CLOV trades turned out.

CLOV in the AI portfolios
Loading…

CLOV News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CLOV in an article yet. Here's the latest on the wider market.

CLOV in the news

About Clover Health Investments

Clover Health offers Medicare Advantage health plans, including PPO and HMO coverage, mainly for Medicare eligible seniors, with a focus on underserved markets. It also provides Clover Assistant, a software platform that gives physicians patient data and insights to help them identify and manage chronic diseases. Its customers include seniors who enroll in its plans and the physicians in its provider networks. The company is based in Jersey City, New Jersey.

Headquarters
Jersey City, NJ